Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia

被引:19
|
作者
Kim, Melissa M. [1 ]
Conyngham, S. Caitlin [1 ]
Smith, Champagnae [1 ]
Higgins, Dana [1 ]
Nassau, Tanner [1 ]
Terrell, Coleman [1 ]
Brady, Kathleen A. [1 ]
机构
[1] Philadelphia Dept Publ Hlth, 1101 Market St,Eighth Floor, Philadelphia, PA 19107 USA
来源
关键词
Outbreak Response; PWID; Social Determinants of Health; Opioid epidemic; HIV Surveillance; SYRINGE EXCHANGE; HIV-INFECTION; USERS; HOMELESSNESS; DIAGNOSES; PROGRAMS; PEOPLE;
D O I
10.1093/infdis/jiaa128
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. In 2018, Philadelphia identified an outbreak of new human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). Although conventional HIV surveillance systems capture individual-level behavioral risk, they are not able to capture the social and environmental factors contributing to rapid transmission. Methods. HIV surveillance data were used to assess demographic, clinical, and behavioral factors for PWID with HIV diagnosed during 2017 and 2018. Social factors such as homelessness, disruption of encampments, and trends in sexual behaviors, drug use and syringe availability among PWID were captured through National HIV Behavioral Surveillance, routine hepatitis and sexually transmitted infection surveillance, and shelter and homeless outreach data. Results. In 2018, there were 71 new infections among PWID, an increase of 115% since 2016. During this time, opioid overdose deaths peaked at 59 deaths per 100 000 persons, 85% of which involved the use of fentanyl. While overall reported homelessness increased, rates of those living unsheltered rose by 13%. The Philadelphia Department of Public Health identified increased injection frequency, encampment closures, and lack of syringe access as promoters of continued HIV transmission. Conclusion. The use of conventional surveillance methods only is inadequate for determining HIV risk during outbreaks. Incorporation of individual and aggregate level data on social and environmental determinants is necessary to develop effective outbreak response interventions.
引用
收藏
页码:S250 / S258
页数:9
相关论文
共 50 条
  • [41] A Mobile Health Tool to Capture Social Determinants of Health and Their Impact on HIV Treatment Outcomes Among People who Use Drugs
    Conway, Caitlin
    Westergaard, Ryan
    Vjorn, Olivia
    Genz, Andrew
    Kirk, Gregory
    Gicquelais, Rachel
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [42] Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection
    Williams, Narissa
    Bossert, Nicholas
    Chen, Yang
    Jaanimagi, Urmo
    Markatou, Marianthi
    Talal, Andrew H.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 102 : 33 - 39
  • [43] Prevalence of Social Determinants of Health Risk Factors Among and Their Impact on Viral Suppression, Consistent Visits, and No-Show Rates Among Persons with HIV Who Identify as Hispanic
    Cowden, Mary
    Clavijo, Ana
    Bitar, Yanis
    Diaz, Monica
    Merced, Xiomara
    Meza, Karla
    Iyengar, Pragnya
    Avery, Ann
    AIDS AND BEHAVIOR, 2025,
  • [44] Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens
    Paraskevis, Dimitrios
    Kostaki, Evangelia
    Nikolopoulos, Georgios K.
    Sypsa, Vana
    Psichogiou, Mina
    Del Amo, Julia
    Hodges-Mameletzis, Ioannis
    Paraskeva, Dimitra
    Skoutelis, Athanasios
    Malliori, Meni
    Williams, Leslie
    Friedman, Samuel R.
    Daikos, Georgios L.
    Hatzakis, Angelos
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (12) : 2078 - 2084
  • [45] Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India
    Mehta, Shruti H.
    McFall, Allison M.
    Srikrishnan, Aylur K.
    Kumar, M. Suresh
    Nandagopal, Paneerselvam
    Cepeda, Javier
    Thomas, David L.
    Sulkowski, Mark S.
    Solomon, Sunil S.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (03):
  • [46] Prevalence of, and risk factors for, human immunodeficiency virus, hepatitis B and hepatitis C infections among men who inject image- and performance-enhancing drugs in England & Wales
    Hope, V.
    McVeigh, J.
    Marongiu, A.
    Evans-Brown, M.
    Smith, J.
    Kimergard, A.
    Croxford, S.
    Beynon, C.
    Parry, J.
    Bellis, P. M.
    Ncube, F.
    HIV MEDICINE, 2013, 14 : 2 - 2
  • [47] Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati/Northern Kentucky, 2017-2018
    Furukawa, Nathan W.
    Blau, Erin F.
    Reau, Zach
    Carlson, David
    Raney, Zachary D.
    Johnson, Tisha K.
    Deputy, Nicholas P.
    Sami, Samira
    McClung, Robert P.
    Neblett-Fanfair, Robyn
    de Fijter, Sietske
    Ingram, Tim
    Thoroughman, Doug
    Vogel, Stephanie
    Lyss, Sheryl B.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : 1961 - 1967
  • [48] Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion
    Chu, Carissa E.
    Wu, Feng
    He, Xi
    Zhou, Kali
    Cheng, Yu
    Cai, Weiping
    Geng, Elvin
    Volberding, Paul
    Tucker, Joseph D.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (02):
  • [49] The impact of the COVID-19 pandemic on HIV infection risk, prevention and testing among persons who inject drugs (PWID) in Rajs']jshahi city of Bangladesh
    Kalam, M. A.
    HIV MEDICINE, 2023, 24 : 223 - 224
  • [50] Prevalence and Predictors of Human Immunodeficiency Virus and Selected Sexually Transmitted Infections Among People Who Inject Drugs in Dar es Salaam, Tanzania: A New Focus to Get to Zero
    Mmbaga, Elia John
    Moen, Kare
    Makyao, Neema
    Leshabari, Melkizedeck
    SEXUALLY TRANSMITTED DISEASES, 2017, 44 (02) : 79 - 84